Home World China grants conditional approval for Pfizer’s COVID-19 drug Paxlovid

China grants conditional approval for Pfizer’s COVID-19 drug Paxlovid

152
0
SHARE
(G.N.S) Dt. 12 Beijing China’s medical products regulator has granted conditional approval for Pfizer’s COVID-19 drug Paxlovid, making it the first oral pill specifically developed to treat the disease cleared in the nation. The National Medical Products Administration said Paxlovid is approved to treat adults who have mild to moderate COVID-19 and high risk of progressing to a severe condition. Further study on the drug needed to be conducted and

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In